Skip to main content
. 2015 Feb 25;107(4):djv018. doi: 10.1093/jnci/djv018

Figure 2.

Figure 2.

Overall survival, Hodgkin’s lymphoma–related mortality, and cause-specific mortality among participants in six consecutive first-line clinical trials, 1975–2008. A) Overall survival. B) Cause-specific mortality from Hodgkin’s lymphoma and causes other than Hodgkin’s lymphoma. C) Cause-specific mortality among 746 treated patients.